Literature DB >> 10999936

The dopamine D3 receptor interacts with itself and the truncated D3 splice variant d3nf: D3-D3nf interaction causes mislocalization of D3 receptors.

K D Karpa1, R Lin, N Kabbani, R Levenson.   

Abstract

We have generated a stable cell line expressing FLAG epitope-tagged D3 dopamine receptors and used this cell line to study D3 receptor-protein interactions. To analyze protein interactions, we separately introduced into the stable cell line either D3 receptors carrying an hemagglutinin (HA) epitope tag, or an HA-tagged version of the D3 receptor splice variant D3nf. A combination of confocal laser microscopy and coimmunoprecipitation was used to assay the formation and expression pattern of D3-D3 homodimers or D3-D3nf heterodimers. When coexpressed in HEK 293 cells, FLAG- and HA-tagged D3 receptors exhibited a similar plasma membrane distribution. Using an HA epitope tag-specific antibody, we coimmunoprecipitated HA- and FLAG-tagged D3 receptors, suggesting that D3 receptors are capable of forming homodimers. Epitope-tagged D3nf polypeptides exhibited a markedly different cellular distribution than D3 receptors. When expressed in HEK 293 cells, either alone or in combination with FLAG-tagged D3 receptors, D3nf exhibited a punctate perinuclear distribution. When D3nf was introduced into the stable D3-expressing cell line, D3 receptors were no longer visualized at the plasma membrane. Instead, D3 and D3nf showed a similar, predominantly cytosolic, localization. Using the HA-specific antibody, we were able to coimmunoprecipitate D3 and D3nf polypeptides from transfected cells. These data suggest the existence of physical interaction between D3 and D3nf. This interaction appears to result in the mislocalization of D3 receptors from the plasma membrane to an intracellular compartment, a finding that could be of significance in the etiology of schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10999936     DOI: 10.1124/mol.58.4.677

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  40 in total

Review 1.  Roles of G-protein-coupled receptor dimerization.

Authors:  Sonia Terrillon; Michel Bouvier
Journal:  EMBO Rep       Date:  2004-01       Impact factor: 8.807

Review 2.  mRNA transcript diversity creates new opportunities for pharmacological intervention.

Authors:  Elizabeth S Barrie; Ryan M Smith; Jonathan C Sanford; Wolfgang Sadee
Journal:  Mol Pharmacol       Date:  2012-02-07       Impact factor: 4.436

3.  Asymmetric conformational changes in a GPCR dimer controlled by G-proteins.

Authors:  Marjorie Damian; Aimée Martin; Danielle Mesnier; Jean-Philippe Pin; Jean-Louis Banères
Journal:  EMBO J       Date:  2006-11-30       Impact factor: 11.598

Review 4.  Controlling protein compartmentalization to overcome disease.

Authors:  James R Davis; Mudit Kakar; Carol S Lim
Journal:  Pharm Res       Date:  2006-09-13       Impact factor: 4.200

5.  Relative expression of D3 dopamine receptor and alternative splice variant D3nf mRNA in high and low responders to novelty.

Authors:  Laurel M Pritchard; Aaron D Logue; Benjamin C Taylor; Rebecca Ahlbrand; Jeffrey A Welge; Yang Tang; Frank R Sharp; Neil M Richtand
Journal:  Brain Res Bull       Date:  2006-07-13       Impact factor: 4.077

6.  Dopamine D2 and D3 receptors are linked to the actin cytoskeleton via interaction with filamin A.

Authors:  R Lin; K Karpa; N Kabbani; P Goldman-Rakic; R Levenson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-24       Impact factor: 11.205

7.  Molecular characterization and analysis of a truncated serotonin receptor gene expressed in neural and reproductive tissues of abalone.

Authors:  Sasiporn Panasophonkul; Somjai Apisawetakan; Scott F Cummins; Patrick S York; Bernard M Degnan; Peter J Hanna; Porncharn Saitongdee; Prasert Sobhon; Prapee Sretarugsa
Journal:  Histochem Cell Biol       Date:  2009-02-13       Impact factor: 4.304

Review 8.  Heteromeric dopamine receptor signaling complexes: emerging neurobiology and disease relevance.

Authors:  Melissa L Perreault; Ahmed Hasbi; Brian F O'Dowd; Susan R George
Journal:  Neuropsychopharmacology       Date:  2013-06-18       Impact factor: 7.853

Review 9.  Alternative splicing of G protein-coupled receptors: physiology and pathophysiology.

Authors:  Danijela Markovic; R A John Challiss
Journal:  Cell Mol Life Sci       Date:  2009-07-23       Impact factor: 9.261

Review 10.  μ-Opioid receptor 6-transmembrane isoform: A potential therapeutic target for new effective opioids.

Authors:  Marino Convertino; Alexander Samoshkin; Josee Gauthier; Michael S Gold; William Maixner; Nikolay V Dokholyan; Luda Diatchenko
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-12-06       Impact factor: 5.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.